Repligen Acquires Engineered Molding Technology

June 29, 2020

Repligen Corporation agreed to acquire Engineered Molding Technology (EMT), an Albany, New York manufacturer of single-use silicone assemblies, connectors and tubing used in biologic drug manufacturing. The purchase expands Repligen’s single-use ProConnex flow-path capabilities, streamlines its supply chain for ATF, and aims to deliver faster lead-times and a more integrated offering for biopharma and CDMO customers; terms were not disclosed and the deal was expected to close in Q3 2020.

Buyers
Repligen Corporation
Targets
Engineered Molding Technology (EMT)
Sellers
Michael Pandori
Industry
Biotechnology
Location
New York, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.